Robeco Institutional Asset Management B.V. lessened its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 21.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,169,848 shares of the company's stock after selling 321,705 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.63% of Docusign worth $78,555,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. V Square Quantitative Management LLC acquired a new stake in shares of Docusign during the 3rd quarter valued at about $27,000. WealthCollab LLC increased its stake in Docusign by 372.4% in the first quarter. WealthCollab LLC now owns 855 shares of the company's stock valued at $41,000 after acquiring an additional 674 shares during the period. Elevation Wealth Partners LLC increased its stake in Docusign by 71.1% in the third quarter. Elevation Wealth Partners LLC now owns 876 shares of the company's stock valued at $59,000 after acquiring an additional 364 shares during the period. Virtus Advisers LLC bought a new stake in Docusign in the second quarter valued at about $47,000. Finally, Rakuten Securities Inc. acquired a new position in Docusign in the second quarter worth about $49,000. Institutional investors and hedge funds own 77.64% of the company's stock.
Docusign Stock Up 1.5%
NASDAQ:DOCU opened at $81.48 on Thursday. The firm has a market cap of $15.23 billion, a PE ratio of 49.68, a price-to-earnings-growth ratio of 2.97 and a beta of 0.86. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $81.62. The company's 50-day moving average price is $67.89 and its two-hundred day moving average price is $55.43.
Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.07. The firm had revenue of $875.75 million for the quarter, compared to analysts' expectations of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The company's quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 earnings per share. On average, research analysts expect that Docusign Inc. will post 2.14 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have commented on DOCU shares. Yorkville Ives assumed coverage on shares of Docusign in a research note on Monday, October 5th. They set an "in-line" rating and a $72.00 price target for the company. Morgan Stanley lifted their price objective on Docusign from $69.00 to $75.00 and gave the company an "equal weight" rating in a report on Friday, September 4th. Robert W. Baird upped their price objective on Docusign from $55.00 to $72.00 and gave the company a "neutral" rating in a research note on Friday, September 4th. Needham & Company LLC reiterated a "hold" rating on shares of Docusign in a research note on Friday, September 4th. Finally, Wells Fargo & Company increased their target price on Docusign from $55.00 to $60.00 and gave the stock an "equal weight" rating in a report on Friday, September 4th. Three analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $67.62.
Check Out Our Latest Report on Docusign
Insiders Place Their Bets
In related news, CFO Blake Grayson sold 30,000 shares of the stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $70.00, for a total transaction of $2,100,000.00. Following the sale, the chief financial officer directly owned 96,429 shares in the company, valued at $6,750,030. This represents a 23.73% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Peter Solvik sold 46,000 shares of the firm's stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $65.24, for a total value of $3,001,040.00. Following the sale, the director directly owned 49,558 shares of the company's stock, valued at $3,233,163.92. This represents a 48.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 165,868 shares of company stock worth $11,121,890 over the last ninety days. 0.59% of the stock is owned by insiders.
Docusign Company Profile
(
Free Report)
DocuSign, Inc is a software company that provides digital agreement and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping customers replace paper-based contracting processes with digital workflows.
The company's offerings include eSignature, contract lifecycle management, identity verification, notarization and agreement analytics tools. These products are designed to support agreement creation, negotiation, execution and post-signature management across functions such as sales, human resources, procurement, legal and finance.
Founded in 2003, DocuSign serves businesses, government organizations and individual users in markets around the world.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.